Introduction
Recent advances in nano and micro-material research have made possible many applications in modern nanomedicine where various particle types have been developed with the potential use as drug carriers for therapeutic purposes (Ferrari, 2005, Peyratout and Dahne, 2004) and as diagnostic imaging tools (Colvin, 2003 , Gao et al. , 2008 . It is now well-established that nanomaterials, as also observed for larger biomaterials upon exposure to biological fluids, such as human plasma, are immediately coated by biomolecules that form a biomolecular layer which represent the key to their biological impacts, hereafter called the "protein corona" (Aggarwal et al. , 2009 , Maiolo et al. , 2015 , Milani et al. , 2012 , Monopoli et al. , 2011 , Nel et al. , 2009 , Rocker et al. , 2009 , Tenzer et al. , 2013 , Wan et al. , 2015 , Yan et al. , 2013 .
This biomolecular corona is typically composed of an outer weakly interacting layer of proteins (the dynamic corona) (Milani, Baldelli Bombelli, 2012) , which is rapidly exchanging with free proteins in the biological milieu, and an inner hard corona of proteins strongly bound to the nanomaterial surface that are slowly exchanging and reside on the surface for longer residence times. Previous studies on several different nanomaterials have shown that from the roughly 3700 proteins present in human plasma, whose abundance varies over several orders of magnitude, only a few tens of proteins with high affinity (for a particular material) are associated with any specific nanomaterial surface with sufficient residence time to provide a biological identity for that nanomaterial (Bigdeli et al. , 2016 , Casals et al. , 2010 , Cedervall et al. , 2007 , Hadjidemetriou et al. , 2015b , Tenzer, Docter, 2013 , Walkey and Chan, 2012 , Wan, Kelly, 2015 . Thus, the biological machinery is not likely to "see" the pristine surface of such materials (Ge et al. , 2011 , Lesniak et al. , 2012 , Walczyk et al. , 2010 .
The properties of nanomaterials such as their shape, charge, surface chemistry, functional groups and material impact the protein corona composition which may lead to different biological consequences (Sund et al. , 2011, Walkey and Chan, 2012) . For example, binding of opsonin proteins (e.g., fibrinogen, complement proteins and immunoglobulins) to particles can lead to recognition by macrophages, (Konduru et al. , 2009 ) promoting cellular uptake (Lunov et al. , 2011) and inflammation, (Boraschi et al. , 2012 , Ishida et al. , 2001 ) while, binding of disosponin proteins (e.g., serum albumin, transferrin and lipoproteins) is likely to favour prolonged circulation time in the blood stream and may confer improved biocompatibility of nanomaterials (Camner et al. , 2002 , Hadjidemetriou et al. , 2015a , Mahmoudi et al. , 2011 .
Recent studies have shown that other biomolecules form the corona and their component has a strong impact on the biological response. For example Wan and co-authors have recently highlighted the importance of the carbohydrates at the bionano interface (Wan, Kelly, 2015) , and increasing studies, using lung lining fluids, have shown how the lipids and the surfactant proteins can modulate the protein corona composition. (Konduru, Tyurina, 2009 , Kumar et al. , 2016 , Raesch et al. , 2015 .
Due to the buoyancy of the MBs, the use of standard physico-chemical characterisation methods and approaches for the MB corona complexes isolation are not easily applicable. We describe here an alternative method which allows the characterization of MB protein coronas in a high throughput manner by means of flow cytometry, a tool used until now mainly in cell biology. By means of this technique we illustrate that flow cytometry is capable of providing information about the MB concentration, on the dispersion properties in complex media and it is also a useful method to isolate MB strongly bound protein corona complexes.
Materials and methods

Microbubbles
The PVA MBs were made of a shell of crosslinked poly(vinyl alcohol), while the Type B MBs were synthesized by embedding iron oxide magnetic nanoparticles into the poly(vinyl alcohol) shell. Various types of layer-by-layer MBs (LBL) were also provided for our studies.
These LBL MBs were all multilayer MBs which were made using the same aminoguanidine shell (e.g., LBL02, shell only), but with different specific materials introduced into the aminoguanidine shell (e.g., LBL 03-11). All the above MBs were in the size range 2~4.5 µm and collectively possessed a similar surface curvature. Various coatings on the MB shells were designed to improve their surface functionality, and improve their use as contrast agents. Table 1 provides a summary descriptions of the MBs used in the study in terms of their shell composition and outer surface layer charge.
Physico-chemical characterization of MBs by flow cytometry
The stock solution of MBs was mixed for 5-10 seconds using a vortex mixer until the MBs were homogeneously dispersed (as determined by visual inspection). 10 6 MBs were diluted in 1ml in relevant media (such as PBS or the biological fluid of choice, such as 6% human plasma, 10% bovine serum, full human plasma and full human blood) and this dose corresponds to a typical dose used for in vivo imaging (Brismar et al. , 2012) . Following incubation the sample was analysed by flow cytometer using an Accuri C6 system (BD Biosciences). MBs sub-populations were isolated in a FACSAria™ III cell sorter (also from BD). Non-fluorescent MBs were detected by their forward and side scattering. The fluid flow in the flow cytometer was fixed at a speed of 14 µl per minute in all cases.
Biological fluid
Human plasma was obtained from the Irish Blood Transfusion Service (IBTS), St. James
Hospital following their internal procedure. Human blood was obtained from three male and three female healthy donors. After collection the plasma was pooled and stored at -80 °C in 2ml aliquots. Human plasma was tested for total protein content using the bicinchoninic acid assay (BCA assay, Pierce) and for protein dispersion by size exclusion chromatography (data not shown). Foetal bovine serum (FBS) serum was obtained from Gibco (Biosciences, Ireland).
On the day of each experiment, biological fluid was allowed to thaw at room temperature until the solution looked clear, then centrifuged for 3minutes at 16,000 rcf. The plasma was diluted to required concentration in 1mM EDTA phosphate buffered saline (PBS).
Protein corona isolation from human plasma
For each MB type, MBs were incubated with the biological fluid of choice (6% plasma, 10% serum or ~100% undiluted plasma) for 1 hour at 37ºC under agitation. They were subsequently allowed to float to the surface of the solution for 120 minutes without agitation and the medium below the MBs was carefully removed with a needle-assembled syringe.
MB-protein corona complexes were then washed 5 times with 1 ml of PBS (allowing the MBs to float to the surface each time for 30 minutes) to remove loosely bound proteins (the so-called soft corona) in order to isolate only the strongly bound proteins (the so-called hard corona). Prior to running on an SDS-PAGE gel, MB-protein corona complexes were counted using a counting chamber (haemocytometer) in phase contrast microscopy and the number of MBs were calculated such that identical numbers of each MB type / replicate were applied for the gel loading.
Sodium dodecyl sulphate polyacrylamide electrophoresis (SDS-PAGE)
To characterize the protein corona formed on the MBs, the isolated MB-protein samples were run in SDS-PAGE gel electrophoresis. Prior to the electrophoresis, the proteins bound to the MBs were denatured and linearized in the presence of surfactant (sodium dodecyl sulphate SDS) and reducing agents (DTT) by boiling the solutions at 95 o C for 5 min. The sample then was loaded into a 10 %polyacrylamide gel and the proteins were separated under electric field in the gel matrix according to the protein molecular weight. To detect the protein bands, the gel was stained using silver staining for protein band detection and using coomassie blue staining for mass spectrometry analysis. The separated proteins were then compared with the standard protein ladder to analyze the protein distribution.
Mass spectrometry
To determine the protein corona composition, the gel lanes containing the protein corona associated with specific MBs were cut out from the gel following SDS-PAGE gel electrophoresis as described above and following by gel based mass spectrometry analysis. where NpSpCk is the percentage of the normalised spectral count for protein k, SpC is the spectral count, and Mw is the molecular weight in KDa for protein k.
Results and Discussion
Characterization of MBs dispersions by flow cytometry
In this study we have tested two distinct types of MBs, those with a polymer shell of poly(vinyl alcohol) (PVA) and MBs prepared via a layer by layer (LBL) approach (Brismar, Grishenkov, 2012 , Cavalieri et al. , 2005 , He et al. , 2012 , Peyratout and Dahne, 2004 . While for the first set of particles, the PVA polymer stabilized the MBs against aggregation (similar to PEG modification), (Cerroni et al. , 2011 , de Gennes, 1987 ) LBL MBs have been modified by layer by layer deposition of polymers on the MBs core. LBL MBs exhibit either a positively or negatively charged surface depending on the peripheral exposed layer and they are electrostatically stabilized due to the repulsion between charged particles. In this study we have tested 10 types of MBs (Table 1) (Figure 3c ). This can be explained by the outmost chitosan layer having a pKa value of 6.3 (Wang et al. , 2006) . Hence, with increasing pH in physiological buffers the charges and the electrostatic stabilization are neutralized, resulting in aggregation of this particular MB sample.
In order to correlate the forward scattering values with the MB size, calibration beads with known sizes (2 µm, 6 µm and 10 µm) have been characterized by flow cytometer. As shown in Figure S1 , a good correlation between the FSC values of the MBs and the size of the calibration beads was observed, and indeed the measured FSC values for the MBs corresponded to sizes between 2 and 6 m.
Overall these findings show that the flow cytometry forward scattering values can be used as a parameter to evaluate the size distribution of MBs in high throughput manner, where distributions of ~15,000 MBs can be characterized within a few seconds, giving full description and quantification of the proportion of the monodisperse versus agglomerated MB sub-populations in the sample.
The same approach was then applied to study the MBs in complex biological fluids (e.g., human plasma). Two different concentrations of human plasma were used in order to determine the behaviour of the MBs under in vitro (6% v/v plasma proteins, roughly corresponding to 4 mg/ml proteins) and in vivo (full plasma proteins) conditions. Figure 5 shows the FSC and SSC for PVA MBs and a gate (labelled as P16) around the MB population. Human plasma (with no MBs) and MBs in PBS were also run as controls to set a threshold to exclude the protein background. By plotting the FSC and SSC versus the number of MBs, we found that the dispersion properties (size and size distribution) of the different MBs were not altered by transfer from PBS into human plasma since the populations overlapped completely. This indicates that no destabilisation of the MBs dispersions occurs as a result of dilution in biological fluids. When human plasma concentration was increased from 6% to 100%, the MBs showed identical distributions, indicating that their dispersion was not affected by the amount of human plasma and that the MBs retained good stability also in these conditions ( Figure 5 ).
Physico-chemical characterization of PVA stabilised MBs after incubation in full human blood (with cells included) has also been performed in order to characterise the MBs after incubation in full blood with cells, and determine eventual binding-aggregation with the cells.
As shown in Figure 6a -b, gates were set to allow to detect and count PVA stabilised MBs (P16), and when human blood alone was analysed by flow cytometry no objects with similar SSC and FSC were detected in the gated area of the MBs (Figure 6 c-d) . However, when the MBs were exposed to human blood no MBs were detected in the same region (Figure 6e-f ).
Most probably, due to the similar size of MBs and red blood cells (erythrocytes), and large excess of erythrocytes compared to the number of MBs in full blood. As erythrocytes in blood are in the range 4.9-5.5 ×10 9 per mL and the MBs added were 10 6 per mL, MB population corresponded only to 0.02% of the total number of objects in full blood, making the detection really challenging in flow cytometry. Thus, in order to better visualize and characterize the MBs in whole blood, after 1 h incubation, samples were centrifuged to pellet the blood cells while the supernatant, containing buoyant MBs, was run and characterized by flow cytometry. We found that the signal from the red blood cells was greatly decreased by the centrifugation step, due to free blood cell removal and only a small amount of blood debris was detected in the gate of the MBs (Figure 6 g-h) . In this way, a much clearer signal could be observed from the MB population, as shown in the FSC and SSC plots ( Figure 6 gh). Furthermore we found that the distribution of the MBs in human blood overlapped with those dispersed in phosphate buffered saline (PBS) (Figure 7 ). This result confirmed that the particle size and distribution of the MBs were not significantly affected by the dispersion medium (PBS or human blood). The same approach can be applied to any large microparticles dispersed in any biological fluid.
Identification of proteins from coronas of microbubbles
To fully assess the biocompatibility of MBs, we have finally investigated the hard protein corona formation after incubation with 10% bovine serum and 6% human plasma (note that the total amount of proteins in these 2 samples is equal, with only the complement proteins being removed in the serum), in order to mimic typical in vitro conditions (i.e., exposure conditions used in cell studies). In addition, MBs were also incubated with full plasma (100%) to simulate the environment of the blood stream. As discussed above, current protocols to isolate particles with their protein coronas are not easily applied to MBs, as they rely on particle sedimentation under centrifugal force, whereas MBs are buoyant and thus do not sediment (Cedervall, Lynch, 2007 , Monopoli, Walczyk, 2011 . By taking advantage of MBs buoyancy, MBs were incubated with plasma and subsequently MB-hard protein corona complexes were isolated as described in Materials and Methods.
Interestingly, strong similarities were observed for all the different types of MBs in the protein coronas recovered after incubation in 6% and in full human plasma. As shown in Figure 8 , a predominant protein band at 70 kDa, later identified as serum albumin, was consistently found in all cases. Other protein bands at 150, 80, 60, 50 and 25 kDa were also observed, with similar patterns across all the different MB samples assessed. No dramatic differences in protein band patterns were found in the coronas of the differently surfacefunctionalized MBs. A similar pattern was also obtained for several different kinds of MBs studied when coronas were formed in serum, rather than plasma, suggesting that the different surface properties of the MBs do not lead to a significant difference in the protein corona composition, likely due to the loss of surface curvature effects present for nanoscale particles.
Mass spectrometry (MS) was then used in order to identify the different classes of proteins in the MBs-protein coronas. The most abundant proteins identified by MS are given in Tables 2   and 3 . The MS analysis confirmed that serum albumin was overall the most abundant protein in the MB-protein coronas after incubation with 6% plasma, 10% serum and full plasma. In fact, we observed that serum albumin accounts for between 8 -55% of the total protein content in the MB coronas. (Ishida, Harashima, 2001, Owens and Peppas, 2006) . Additionally, the ratio between disopsonin and opsonin proteins was high. This may suggest that the MBs in 6% plasma and 10% serum are not likely to trigger phagocytic pathways via their protein corona (for example, for in vitro cell studies), indicating a high biocompatibility of the MBs. Similarly, in full plasma, the MBs had a similar corona composition as in 6% plasma and 10% serum. However, the serum albumin showed the lowest abundance (8.1~17.1%) in full plasma, compared to 31.6 -46% and 50.6 -52.9% in 6% plasma and 10% serum respectively. This suggested that protein binding to MBs was significantly affected by the total protein concentrations, and that in vitro studies may not be entirely predictive of in vivo behaviour. Several disopsonin proteins (e.g., serum
albumin, serotransferrin and lipoproteins) were among the major components of the protein corona formed on all types of MBs (PVA, Type B, LBL02, and LBL04) also in full plasma, however several opsonin biomolecules were found as corona binding proteins when exposed to full plasma. In particular Immunoglobulin G and complement C3 were detected in the corona suggesting that they might promote recognition by macrophages, resulting in the potential to induce an immune response and opsonisation (Hamad et al. , 2010) . However, the presence of these biomolecules in the corona does not directly imply biocompatibility concerns as immunogenic epitopes of these proteins, such as the constant regions of the antibody, as they can be buried in the biomolecular corona and they might not be available for binding. . Overall the protein corona proteomics suggest high biocompability of the MB in vitro and in vivo conditions however further studies will map the binding sites of the corona in order to fully evaluate their impact in biological environment.
Conclusions
We have developed and demonstrated the use of flow cytometry as a new technique to characterize the dispersions of polymer coated MBs in complex biological fluids such as human plasma and full blood where this method allows to overcome the experimental challenges associated with working with such buoyant materials. Flow cytometry sorting has also been used as an efficient novel tool to separate monodisperse MBs from multipopulation dispersions (e.g. cellular and/or MB debris and MB agglomerate) even where the single MBs constituted the minority of the sample and it can be used as a useful postsynthesis cleaning step, increasing the quality of the contrast agent (Figure 3) . By setting appropriate gate(s) for forward and side scattering, MBs can be isolated in less than 1h per mL of blood in an automatic manner. Importantly, this approach can also be applied to investigate interactions of such particles with full blood, and other biological media, and therefore predict the likely effective interactions between MBs and cells, in situ.
In addition, we believe that this method can be applied to recover the MBs after their in vivo exposure, such as in animal studies. The isolation of MBs by flow cytometry is relatively easy and fast compared to previously applied methods, such as phase contrast microscopy.
While using high resolution microscopy only 10-100 MBs can be analyzed, within 20 min,
whereas the flow cytometer can analyze more than 50,000 MBs per minute.
Thus here, we have this method to characterise multiple types of surface functionalized, polymer coated MBs, developed for multimodal imaging applications as in vivo contrast agents. Assessment of the composition of their protein coronas following incubation under in vitro (6% plasma or 10% serum) and in vivo (full human plasma) conditions have been carried out in order to study the biocompatibility of several representative MBs. This study shows that there is very little difference observed in terms of the proteins bound to the different types of MBs, suggesting that lack of surface curvature of the MBs may play a more prominent role than surface functionalization in driving protein binding to the MBs. Since
MBs are generally in the size range of 2~6 µm in diameter, they may be large enough to 13 behave as flat surfaces for binding of proteins. This is very different from protein binding to nanoscale objects, where even small variations in surface properties play important roles in protein corona composition driven or enhanced by their high surface curvature.
Mass spectrometry results indicated the presence of several disopsonin proteins in the MB coronas, e.g. serum albumin, transferrin and apolipoprotein A1, which are known to suppress phagocytosis. A lack of opsonin proteins, such as immunoglobulin and complement proteins which are known to promote phagocytosis, was observed in 10% serum treated MBs.
Additionally, it was found that since the ratio between disopsopin and opsonin proteins was 
